Target intelligence / Profile preview

U1 small nuclear RNA 35 pseudogene (RNU1-35P)

Target: RNU1-35P
Molecular classification: Other (Pseudogene; Non-coding RNA-related element)

Overview

RNU1-35P is a pseudogene derived from the U1 small nuclear RNA gene family, characterized by high sequence homology but lacking the regulatory elements and functional coding capacity of canonical U1 snRNA genes. U1 snRNA is an integral component of the U1 small nuclear ribonucleoprotein (snRNP), which recognizes 5′ splice sites in pre-mRNA and initiates spliceosome assembly for intron removal. Pseudogenes like RNU1-35P result from gene duplication and mutation events, are generally nonfunctional, and can be genetically clustered apart from true U1 genes. They are not drug targets and have no confirmed biological function or disease association. Their main scientific relevance is in evolutionary genomics and gene regulation studies, but they have no established clinical or therapeutic significance. If you require details on the functional molecule involved in splicing, see entries for "U1 small nuclear RNA" (RNU1-1 and related genes). RNU1-35P does not substitute for those functions.

Other names: RNU1-35PU1 small nuclear RNA pseudogene 35

Biological functions

None for the pseudogene itself. The canonical U1 snRNA (not this pseudogene) functions in splicing of pre-mRNA. Pseudogenes themselves do not participate in these biological processes.

Disease associations

None for RNU1-35P. The canonical U1 snRNA and related components have links to disease when disrupted, but the pseudogene is not directly implicated.

Beyond the preview

Go deeper on U1 small nuclear RNA 35 pseudogene (RNU1-35P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U1 small nuclear RNA 35 pseudogene (RNU1-35P).

Explore the full profile